Estelle has joined Kayentis, a global eCOA solutions provider, in 2019, to consolidate the scientific expertise of the company and drive patient and site centric developments.
Estelle has more than 20 years’ experience in the pharmaceutical industry, in both pre-clinical and clinical research. She joined Pfizer in early 2012 after having worked for both other big pharmas’ and biotech companies. She led projects from phase 1 through 4 in multiple therapeutic areas and has also solid expertise in the Non-Interventional space as well as in Clinical Pharmacology.